Skip to content

Clinical trials

Terminated Small Cell Lung Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Terminated Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20141
20151
20161
20173
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center3
Bayer2
AbbVie1
Hoffmann-La Roche1
Kartos Therapeutics, Inc.1
Kyowa Kirin Korea Co., Ltd.1
MacroGenics1
Millennium Pharmaceuticals, Inc.1
National Cancer Center, Korea1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma13
Carcinoma, Non-Small-Cell Lung2
Melanoma2
Squamous Cell Carcinoma of Head and Neck2
Anus Neoplasms1
Carcinoma, Small Cell1
Esophageal Squamous Cell Carcinoma1
Mesothelioma1
Neoplasms1
Ovarian Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.